Paradigm shift in the treatment of myasthenia gravis
Complement inhibition by eculizumab
Paradigm shift in the treatment of myasthenia gravis
it
Dr. Francesco Saccà
Treatment of myasthenia gravis: the still open challenges
it
Dr. Michelangelo Maestri
Neuromyelitis optica and multiple sclerosis, similarities and differences
it
Dr. Lucia Moiola
Neuromyelitis optica in the light of new treatments
it
Dr. Carla Tortorella
Eculizumab: what therapeutic innovations in myasthenia gravis
it
Dr. Vincenzo Di Stefano